.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Teva
McKinsey
Cerilliant
Cipla
Baxter
Covington
Harvard Business School
Moodys
Boehringer Ingelheim

Generated: July 23, 2017

DrugPatentWatch Database Preview

CAPITAL SOLEIL 15 Drug Profile

« Back to Dashboard

Which patents cover Capital Soleil 15, and what generic Capital Soleil 15 alternatives are available?

Capital Soleil 15 is a drug marketed by Loreal Usa and is included in one NDA.

The generic ingredient in CAPITAL SOLEIL 15 is avobenzone; ecamsule; octocrylene. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the avobenzone; ecamsule; octocrylene profile page.

Summary for Tradename: CAPITAL SOLEIL 15

Patents:0
Applicants:1
NDAs:1
Clinical Trials: see list41
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CAPITAL SOLEIL 15 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Loreal Usa
CAPITAL SOLEIL 15
avobenzone; ecamsule; octocrylene
CREAM;TOPICAL021501-001Oct 2, 2006OTCYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
McKinsey
Daiichi Sankyo
QuintilesIMS
Harvard Business School
Dow
Cantor Fitzgerald
Cipla
Express Scripts
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot